News

Check out market updates

Viridian Therapeutics closes 2020 with $127.6M in cash

BOULDER — Viridian Therapeutics Inc. (Nasdaq: VRDN) said it has the cash to keep it afloat through late 2023 after […]
Source: BizWest

Leave a Reply

Your email address will not be published. Required fields are marked *

X